From IMPERIALism to EMINENence: The Noble Rise of the Second-Generation Peripheral Drug-Eluting Stent.

[1]  M. Fujihara,et al.  1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice: Predictors of Restenosis and Aneurysmal Degeneration. , 2022, JACC. Cardiovascular interventions.

[2]  R. Virmani,et al.  Vascular Response of a Polymer-free, Paclitaxel-coated Stent (Zilver PTX®) Versus a Polymer-coated, Paclitaxel-eluting Stent (Eluvia®) in Healthy Swine Femoropopliteal Arteries. , 2021, Journal of vascular and interventional radiology : JVIR.

[3]  P. Desgranges,et al.  A Polymer-Free Paclitaxel-Eluting Stent Versus a Bare-Metal Stent for De Novo Femoropopliteal Lesions: The BATTLE Trial. , 2020, JACC. Cardiovascular interventions.

[4]  F. Vermassen,et al.  Effectiveness and Safety of a Paclitaxel-Eluting Stent for Superficial Femoral Artery Lesions up to 190 mm: One-Year Outcomes of the Single-Arm IMPERIAL Long Lesion Substudy of the Eluvia Drug-Eluting Stent , 2020, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[5]  A Ross Naylor,et al.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b , 2018, European heart journal.

[6]  R. Bersin,et al.  SCAI appropriate use criteria for peripheral arterial interventions: An update , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  Raimund Erbel,et al.  [2011 ESC guidelines on the diagnosis and treatment of peripheral artery diseases]. , 2012, Revue medicale de Liege.

[8]  John V. White,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[9]  R. Rutherford,et al.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.